Preferred Label : Nordic Regimen;
NCIt synonyms : R-MaxiCHOP Plus R-HDAraC; Rituximab Plus Maxi-CHOP Alternating with Rituximab Plus HD Ara-C; Rituximab Plus Maxi-CHOP Alternating with Rituximab Plus High-Dose Cytarabine; Rituximab with Alternating Cycles of Maxi-CHOP and High-dose Cytarabine; Maxi-R-CHOP/R-HiDAC; Rituximab Plus Cyclophosphamide/Vincristine/Doxorubicin/Prednisone Alternating with
Rituximab Plus High-Dose Cytarabine; Rituximab/Maxi-CHOP Alternating with Rituximab/High-Dose Cytarabine; Rituximab Plus Cyclophosphamide/Hydroxydaunorubicin/Oncovin/Prednisone and R-HD-Ara-C; Nordic;
NCIt related terms : maxi-R-CHOP/R-HiDAC (rituximab-rixa); maxi-R-CHOP/R-HiDAC (rituximab-abbs); maxi-R-CHOP/R-HiDAC (rituximab-rite); maxi-R-CHOP/R-HiDAC (rituximab-rixi); maxi-R-CHOP/R-HiDAC (rituximab-arrx); maxi-R-CHOP/R-HiDAC (rituximab-blit); maxi-R-CHOP/R-HiDAC (rituximab-pvvr);
NCIt definition : A regimen consisting of cycles of rituximab with cyclophosphamide, doxorubicin, vincristine
and prednisone (Maxi-CHOP), alternating with rituximab with high-dose (HD) cytarabine
that can be used in the treatment of mantle cell lymphoma (MCL).;
NCI Metathesaurus CUI : CL538284;
Codes from synonyms : 24592; 128459; 127988; 128616; 128773; 128302; 127831; 128145;
Origin ID : C140110;
UMLS CUI : C4682707;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
